# Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases

> **NCT05692037** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Zhongda Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Unresectable Colorectal Liver Metastases

## Interventions

- **COMBINATION_PRODUCT:** Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres

## Key facts

- **NCT ID:** NCT05692037
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-28
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05692037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05692037, "Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05692037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*